ArticleCancers2022

Upregulation of Receptor Tyrosine Kinase Activity and Stemness as Resistance Mechanisms to Akt Inhibitors in Breast Cancer.

Tiffany Tsang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.